Literature DB >> 12823765

Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers.

C K Hurley1, M Fernandez Vina, M Setterholm.   

Abstract

Today, more than 50 registries of HLA-typed potential adult hematopoietic stem cell donors have been established in 40 countries and include more than 7.5 million volunteers. HLA testing of new volunteers includes HLA-A, -B and often -DR typing at low to intermediate resolution. Searching patients are tested for these same loci, preferably at a higher level of resolution. Over 95,000 patient searches are received by registries annually resulting in approximately 4660 unrelated transplants. In 2001, nearly one-third of transplants involved a patient in one country receiving stem cells from a donor in another. The diversity of the HLA system complicates the search process, requiring sophisticated registry algorithms for matching, and expertise in allele and haplotype frequencies and associations to design search strategies. Within registries, HLA frequency data have been used to evaluate optimal registry size and composition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823765     DOI: 10.1034/j.1399-0039.2003.00096.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

Review 1.  Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care.

Authors:  Razvan Diaconescu; Rainer Storb
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-28       Impact factor: 4.553

2.  Hapl-o-Mat: open-source software for HLA haplotype frequency estimation from ambiguous and heterogeneous data.

Authors:  Christian Schäfer; Alexander H Schmidt; Jürgen Sauter
Journal:  BMC Bioinformatics       Date:  2017-05-30       Impact factor: 3.169

3.  Racial and Ethnic Differences in Attitudes, Perceptions, and Knowledge about Unrelated Hematopoietic Stem Cell Donation: A Study of Younger Newly Recruited Potential Donors.

Authors:  Ahmed B Hamed; Jessica G Bruce; Vidya Kuniyil; Deborah Mattila; Eric P Williams; Mary Amanda Dew; Larissa Myaskovsky; Dennis L Confer; Galen E Switzer
Journal:  Transplant Cell Ther       Date:  2022-03-15

4.  Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.

Authors:  Marco Mielcarek; Barry E Storer; Brenda M Sandmaier; Mohamed L Sorror; David G Maloney; Effie Petersdorf; Paul J Martin; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

5.  [The impact of stem cell therapy in hematology and oncology].

Authors:  R Marks; J Finke
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

6.  Fluoxetine reduces murine graft-versus-host disease by induction of T cell immunosuppression.

Authors:  Veerle Gobin; Katleen Van Steendam; Sabine Fevery; Kelly Tilleman; An D Billiau; Damiaan Denys; Dieter L Deforce
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-04       Impact factor: 4.147

7.  HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population.

Authors:  S J Mack; B Tu; A Lazaro; R Yang; A K Lancaster; K Cao; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2008-10-24

Review 8.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 9.  Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.

Authors:  Frédéric Baron; Rainer Storb
Journal:  Springer Semin Immunopathol       Date:  2004-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.